HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-JUN-10 3NPC TITLE CRYSTAL STRUCTURE OF JNK2 COMPLEXED WITH BIRB796 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 9; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1-364; COMPND 5 SYNONYM: MAP KINASE 9, MAPK 9, STRESS-ACTIVATED PROTEIN KINASE JNK2, COMPND 6 C-JUN N-TERMINAL KINASE 2, JNK-55; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK9, JNK2, PRKM9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS DFG-OUT, PROTEIN KINASE, TRANSFERASE, ATP BINDING, TYPE II KINASE KEYWDS 2 INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,M.GHATE REVDAT 3 06-SEP-23 3NPC 1 REMARK SEQADV REVDAT 2 01-SEP-10 3NPC 1 JRNL REVDAT 1 11-AUG-10 3NPC 0 JRNL AUTH A.KUGLSTATTER,M.GHATE,S.TSING,A.G.VILLASENOR,D.SHAW, JRNL AUTH 2 J.W.BARNETT,M.F.BROWNER JRNL TITL X-RAY CRYSTAL STRUCTURE OF JNK2 COMPLEXED WITH THE P38ALPHA JRNL TITL 2 INHIBITOR BIRB796: INSIGHTS INTO THE RATIONAL DESIGN OF JRNL TITL 3 DFG-OUT BINDING MAP KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 5217 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20655210 JRNL DOI 10.1016/J.BMCL.2010.06.157 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 31845 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1698 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2279 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 123 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5762 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.46000 REMARK 3 B22 (A**2) : 1.57000 REMARK 3 B33 (A**2) : -1.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.267 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.169 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.990 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5984 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8125 ; 1.157 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 711 ; 5.676 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 275 ;35.735 ;24.400 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1047 ;16.402 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;20.146 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 891 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4526 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2768 ; 0.195 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4106 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 331 ; 0.149 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 102 ; 0.174 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.202 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3684 ; 0.612 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5810 ; 1.040 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2662 ; 1.327 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2315 ; 2.133 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3NPC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000060111. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33595 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.56900 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3E7O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 0.1M SODIUM CHLORIDE, 1.6M REMARK 280 AMMONIUM SULFATE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.08500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.05450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.16950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.05450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.08500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.16950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 76.17000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -46.16950 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 56.05450 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 LYS A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 VAL A 6 REMARK 465 GLU A 364 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 LYS B 3 REMARK 465 SER B 4 REMARK 465 LYS B 5 REMARK 465 VAL B 6 REMARK 465 ASP B 7 REMARK 465 GLU B 364 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 8 17.46 57.12 REMARK 500 ALA A 16 -135.02 57.22 REMARK 500 ARG A 59 76.40 9.28 REMARK 500 ASN A 81 72.31 -161.72 REMARK 500 GLN A 102 -54.16 -136.70 REMARK 500 ARG A 150 -19.57 76.28 REMARK 500 GLN A 226 75.50 -101.16 REMARK 500 ALA B 16 -138.75 57.89 REMARK 500 ARG B 59 81.21 12.96 REMARK 500 ASN B 81 77.93 -162.40 REMARK 500 GLN B 102 -55.61 -128.03 REMARK 500 ARG B 150 -11.54 75.23 REMARK 500 PHE B 170 35.85 -93.49 REMARK 500 THR B 228 -97.24 -86.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B96 A 365 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B96 B 365 DBREF 3NPC A 1 364 UNP P45984 MK09_HUMAN 1 364 DBREF 3NPC B 1 364 UNP P45984 MK09_HUMAN 1 364 SEQADV 3NPC LYS A 3 UNP P45984 ASP 3 ENGINEERED MUTATION SEQADV 3NPC VAL A 6 UNP P45984 CYS 6 ENGINEERED MUTATION SEQADV 3NPC ASN A 8 UNP P45984 SER 8 ENGINEERED MUTATION SEQADV 3NPC GLU A 14 UNP P45984 GLN 14 ENGINEERED MUTATION SEQADV 3NPC ALA A 203 UNP P45984 LYS 203 ENGINEERED MUTATION SEQADV 3NPC ALA A 204 UNP P45984 GLU 204 ENGINEERED MUTATION SEQADV 3NPC ALA A 250 UNP P45984 LYS 250 ENGINEERED MUTATION SEQADV 3NPC ALA A 251 UNP P45984 LYS 251 ENGINEERED MUTATION SEQADV 3NPC LYS B 3 UNP P45984 ASP 3 ENGINEERED MUTATION SEQADV 3NPC VAL B 6 UNP P45984 CYS 6 ENGINEERED MUTATION SEQADV 3NPC ASN B 8 UNP P45984 SER 8 ENGINEERED MUTATION SEQADV 3NPC GLU B 14 UNP P45984 GLN 14 ENGINEERED MUTATION SEQADV 3NPC ALA B 203 UNP P45984 LYS 203 ENGINEERED MUTATION SEQADV 3NPC ALA B 204 UNP P45984 GLU 204 ENGINEERED MUTATION SEQADV 3NPC ALA B 250 UNP P45984 LYS 250 ENGINEERED MUTATION SEQADV 3NPC ALA B 251 UNP P45984 LYS 251 ENGINEERED MUTATION SEQRES 1 A 364 MET SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL SEQRES 2 A 364 GLU VAL ALA ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 364 GLN GLN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 364 VAL CYS ALA ALA PHE ASP THR VAL LEU GLY ILE ASN VAL SEQRES 5 A 364 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 364 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU LEU LYS SEQRES 7 A 364 CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL SEQRES 8 A 364 PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 364 TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 364 VAL ILE HIS MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 364 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 364 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 364 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 364 PHE GLY LEU ALA ARG THR ALA CYS THR ASN PHE MET MET SEQRES 15 A 364 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 364 VAL ILE LEU GLY MET GLY TYR ALA ALA ASN VAL ASP ILE SEQRES 17 A 364 TRP SER VAL GLY CYS ILE MET GLY GLU LEU VAL LYS GLY SEQRES 18 A 364 CYS VAL ILE PHE GLN GLY THR ASP HIS ILE ASP GLN TRP SEQRES 19 A 364 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO SER ALA GLU SEQRES 20 A 364 PHE MET ALA ALA LEU GLN PRO THR VAL ARG ASN TYR VAL SEQRES 21 A 364 GLU ASN ARG PRO LYS TYR PRO GLY ILE LYS PHE GLU GLU SEQRES 22 A 364 LEU PHE PRO ASP TRP ILE PHE PRO SER GLU SER GLU ARG SEQRES 23 A 364 ASP LYS ILE LYS THR SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 364 LYS MET LEU VAL ILE ASP PRO ASP LYS ARG ILE SER VAL SEQRES 25 A 364 ASP GLU ALA LEU ARG HIS PRO TYR ILE THR VAL TRP TYR SEQRES 26 A 364 ASP PRO ALA GLU ALA GLU ALA PRO PRO PRO GLN ILE TYR SEQRES 27 A 364 ASP ALA GLN LEU GLU GLU ARG GLU HIS ALA ILE GLU GLU SEQRES 28 A 364 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASP TRP GLU SEQRES 1 B 364 MET SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL SEQRES 2 B 364 GLU VAL ALA ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 B 364 GLN GLN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 B 364 VAL CYS ALA ALA PHE ASP THR VAL LEU GLY ILE ASN VAL SEQRES 5 B 364 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 B 364 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU LEU LYS SEQRES 7 B 364 CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL SEQRES 8 B 364 PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL SEQRES 9 B 364 TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 B 364 VAL ILE HIS MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 B 364 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 B 364 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 B 364 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 B 364 PHE GLY LEU ALA ARG THR ALA CYS THR ASN PHE MET MET SEQRES 15 B 364 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 B 364 VAL ILE LEU GLY MET GLY TYR ALA ALA ASN VAL ASP ILE SEQRES 17 B 364 TRP SER VAL GLY CYS ILE MET GLY GLU LEU VAL LYS GLY SEQRES 18 B 364 CYS VAL ILE PHE GLN GLY THR ASP HIS ILE ASP GLN TRP SEQRES 19 B 364 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO SER ALA GLU SEQRES 20 B 364 PHE MET ALA ALA LEU GLN PRO THR VAL ARG ASN TYR VAL SEQRES 21 B 364 GLU ASN ARG PRO LYS TYR PRO GLY ILE LYS PHE GLU GLU SEQRES 22 B 364 LEU PHE PRO ASP TRP ILE PHE PRO SER GLU SER GLU ARG SEQRES 23 B 364 ASP LYS ILE LYS THR SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 B 364 LYS MET LEU VAL ILE ASP PRO ASP LYS ARG ILE SER VAL SEQRES 25 B 364 ASP GLU ALA LEU ARG HIS PRO TYR ILE THR VAL TRP TYR SEQRES 26 B 364 ASP PRO ALA GLU ALA GLU ALA PRO PRO PRO GLN ILE TYR SEQRES 27 B 364 ASP ALA GLN LEU GLU GLU ARG GLU HIS ALA ILE GLU GLU SEQRES 28 B 364 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASP TRP GLU HET B96 A 365 39 HET B96 B 365 39 HETNAM B96 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2- HETNAM 2 B96 MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA FORMUL 3 B96 2(C31 H37 N5 O3) FORMUL 5 HOH *290(H2 O) HELIX 1 1 ASN A 63 CYS A 79 1 17 HELIX 2 2 CYS A 116 VAL A 118 5 3 HELIX 3 3 ASP A 124 ALA A 145 1 22 HELIX 4 4 LYS A 153 SER A 155 5 3 HELIX 5 5 THR A 188 ARG A 192 5 5 HELIX 6 6 ALA A 193 LEU A 198 1 6 HELIX 7 7 ASN A 205 GLY A 221 1 17 HELIX 8 8 ASP A 229 GLY A 242 1 14 HELIX 9 9 SER A 245 ALA A 250 1 6 HELIX 10 10 GLN A 253 ARG A 263 1 11 HELIX 11 11 LYS A 270 PHE A 275 1 6 HELIX 12 12 PRO A 276 PHE A 280 5 5 HELIX 13 13 SER A 284 LEU A 302 1 19 HELIX 14 14 SER A 311 HIS A 318 1 8 HELIX 15 15 HIS A 318 VAL A 323 1 6 HELIX 16 16 ASP A 326 GLU A 331 1 6 HELIX 17 17 ALA A 348 ASP A 362 1 15 HELIX 18 18 ARG B 59 GLN B 62 5 4 HELIX 19 19 ASN B 63 CYS B 79 1 17 HELIX 20 20 CYS B 116 VAL B 118 5 3 HELIX 21 21 ASP B 124 ALA B 145 1 22 HELIX 22 22 LYS B 153 SER B 155 5 3 HELIX 23 23 THR B 188 ARG B 192 5 5 HELIX 24 24 ALA B 193 LEU B 198 1 6 HELIX 25 25 ASN B 205 GLY B 221 1 17 HELIX 26 26 ASP B 229 GLY B 242 1 14 HELIX 27 27 SER B 245 ALA B 251 1 7 HELIX 28 28 GLN B 253 ASN B 262 1 10 HELIX 29 29 LYS B 270 PHE B 275 1 6 HELIX 30 30 PRO B 276 PHE B 280 5 5 HELIX 31 31 SER B 284 LEU B 302 1 19 HELIX 32 32 SER B 311 ARG B 317 1 7 HELIX 33 33 HIS B 318 VAL B 323 1 6 HELIX 34 34 ASP B 326 GLU B 331 1 6 HELIX 35 35 ASP B 339 GLU B 344 1 6 HELIX 36 36 ALA B 348 TRP B 363 1 16 SHEET 1 A 2 PHE A 10 VAL A 15 0 SHEET 2 A 2 SER A 18 LEU A 23 -1 O PHE A 20 N VAL A 13 SHEET 1 B 6 ASN A 90 PHE A 92 0 SHEET 2 B 6 VAL A 104 GLU A 109 -1 O VAL A 107 N ASN A 90 SHEET 3 B 6 ILE A 50 LEU A 57 -1 N LYS A 55 O LEU A 106 SHEET 4 B 6 ILE A 39 ASP A 45 -1 N ALA A 43 O VAL A 52 SHEET 5 B 6 TYR A 26 SER A 34 -1 N LYS A 30 O ALA A 42 SHEET 6 B 6 PHE A 180 MET A 181 -1 O PHE A 180 N SER A 34 SHEET 1 C 3 ALA A 113 ASN A 114 0 SHEET 2 C 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113 SHEET 3 C 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158 SHEET 1 D 2 PHE B 10 VAL B 15 0 SHEET 2 D 2 SER B 18 LEU B 23 -1 O PHE B 20 N VAL B 13 SHEET 1 E 6 ASN B 90 PHE B 92 0 SHEET 2 E 6 VAL B 104 GLU B 109 -1 O VAL B 107 N ASN B 90 SHEET 3 E 6 ILE B 50 LEU B 57 -1 N LYS B 55 O LEU B 106 SHEET 4 E 6 ILE B 39 ASP B 45 -1 N ALA B 43 O VAL B 52 SHEET 5 E 6 TYR B 26 SER B 34 -1 N GLN B 27 O PHE B 44 SHEET 6 E 6 PHE B 180 MET B 181 -1 O PHE B 180 N SER B 34 SHEET 1 F 3 ALA B 113 ASN B 114 0 SHEET 2 F 3 ILE B 157 VAL B 159 -1 O VAL B 159 N ALA B 113 SHEET 3 F 3 LEU B 165 ILE B 167 -1 O LYS B 166 N VAL B 158 SITE 1 AC1 17 VAL A 40 ALA A 53 LYS A 55 ARG A 69 SITE 2 AC1 17 GLU A 73 LEU A 76 ILE A 86 LEU A 106 SITE 3 AC1 17 MET A 108 LEU A 110 MET A 111 LEU A 142 SITE 4 AC1 17 LEU A 168 ASP A 169 PHE A 170 HOH A 382 SITE 5 AC1 17 HOH A 387 SITE 1 AC2 14 ALA B 53 ARG B 69 GLU B 73 LEU B 77 SITE 2 AC2 14 ILE B 86 LEU B 106 MET B 108 LEU B 110 SITE 3 AC2 14 MET B 111 LEU B 168 ASP B 169 PHE B 170 SITE 4 AC2 14 HOH B 371 HOH B 388 CRYST1 76.170 92.339 112.109 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013129 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010830 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008920 0.00000